nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitagliptin—ABCB1—Dactinomycin—muscle cancer	0.172	0.212	CbGbCtD
Sitagliptin—CYP2C8—Etoposide—muscle cancer	0.143	0.177	CbGbCtD
Sitagliptin—ABCB1—Vincristine—muscle cancer	0.106	0.131	CbGbCtD
Sitagliptin—ABCB1—Etoposide—muscle cancer	0.0969	0.12	CbGbCtD
Sitagliptin—ABCB1—Doxorubicin—muscle cancer	0.0661	0.0817	CbGbCtD
Sitagliptin—ABCB1—Methotrexate—muscle cancer	0.064	0.0792	CbGbCtD
Sitagliptin—CYP3A4—Vincristine—muscle cancer	0.0634	0.0784	CbGbCtD
Sitagliptin—CYP3A4—Etoposide—muscle cancer	0.0581	0.0718	CbGbCtD
Sitagliptin—CYP3A4—Doxorubicin—muscle cancer	0.0396	0.049	CbGbCtD
Sitagliptin—Pharyngitis—Dactinomycin—muscle cancer	0.00144	0.00752	CcSEcCtD
Sitagliptin—Depression—Vincristine—muscle cancer	0.00144	0.00752	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Vincristine—muscle cancer	0.00142	0.00739	CcSEcCtD
Sitagliptin—Erythema multiforme—Dactinomycin—muscle cancer	0.00137	0.00717	CcSEcCtD
Sitagliptin—Hypoaesthesia—Vincristine—muscle cancer	0.00129	0.00674	CcSEcCtD
Sitagliptin—Urinary tract disorder—Vincristine—muscle cancer	0.00128	0.00669	CcSEcCtD
Sitagliptin—Connective tissue disorder—Vincristine—muscle cancer	0.00127	0.00665	CcSEcCtD
Sitagliptin—Urethral disorder—Vincristine—muscle cancer	0.00127	0.00664	CcSEcCtD
Sitagliptin—Cardiac disorder—Vincristine—muscle cancer	0.0012	0.00628	CcSEcCtD
Sitagliptin—Cellulitis—Doxorubicin—muscle cancer	0.00119	0.00623	CcSEcCtD
Sitagliptin—Pneumonia—Etoposide—muscle cancer	0.00118	0.00615	CcSEcCtD
Sitagliptin—Angiopathy—Vincristine—muscle cancer	0.00118	0.00614	CcSEcCtD
Sitagliptin—Ill-defined disorder—Dactinomycin—muscle cancer	0.00117	0.00612	CcSEcCtD
Sitagliptin—Infestation NOS—Etoposide—muscle cancer	0.00117	0.00611	CcSEcCtD
Sitagliptin—Infestation—Etoposide—muscle cancer	0.00117	0.00611	CcSEcCtD
Sitagliptin—Mediastinal disorder—Vincristine—muscle cancer	0.00117	0.0061	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00116	0.00606	CcSEcCtD
Sitagliptin—Renal failure—Etoposide—muscle cancer	0.00115	0.00601	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Etoposide—muscle cancer	0.00115	0.00599	CcSEcCtD
Sitagliptin—Malaise—Dactinomycin—muscle cancer	0.00114	0.00595	CcSEcCtD
Sitagliptin—Mental disorder—Vincristine—muscle cancer	0.00114	0.00593	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Etoposide—muscle cancer	0.00111	0.00578	CcSEcCtD
Sitagliptin—Musculoskeletal pain—Doxorubicin—muscle cancer	0.0011	0.00573	CcSEcCtD
Sitagliptin—Neck pain—Doxorubicin—muscle cancer	0.0011	0.00573	CcSEcCtD
Sitagliptin—Back pain—Vincristine—muscle cancer	0.00109	0.0057	CcSEcCtD
Sitagliptin—Myalgia—Dactinomycin—muscle cancer	0.00108	0.00562	CcSEcCtD
Sitagliptin—Discomfort—Dactinomycin—muscle cancer	0.00106	0.00555	CcSEcCtD
Sitagliptin—Hypoaesthesia—Etoposide—muscle cancer	0.00105	0.00546	CcSEcCtD
Sitagliptin—Urinary tract disorder—Etoposide—muscle cancer	0.00104	0.00542	CcSEcCtD
Sitagliptin—Urethral disorder—Etoposide—muscle cancer	0.00103	0.00538	CcSEcCtD
Sitagliptin—Infection—Dactinomycin—muscle cancer	0.00102	0.00535	CcSEcCtD
Sitagliptin—Vertigo—Vincristine—muscle cancer	0.00101	0.0053	CcSEcCtD
Sitagliptin—Erythema multiforme—Etoposide—muscle cancer	0.000993	0.00519	CcSEcCtD
Sitagliptin—Renal failure acute—Methotrexate—muscle cancer	0.000985	0.00514	CcSEcCtD
Sitagliptin—Eye disorder—Etoposide—muscle cancer	0.000982	0.00513	CcSEcCtD
Sitagliptin—Cardiac disorder—Etoposide—muscle cancer	0.000975	0.00509	CcSEcCtD
Sitagliptin—Hypertension—Vincristine—muscle cancer	0.000975	0.00509	CcSEcCtD
Sitagliptin—Myalgia—Vincristine—muscle cancer	0.000961	0.00502	CcSEcCtD
Sitagliptin—Angiopathy—Etoposide—muscle cancer	0.000953	0.00498	CcSEcCtD
Sitagliptin—Immune system disorder—Etoposide—muscle cancer	0.000949	0.00495	CcSEcCtD
Sitagliptin—Mediastinal disorder—Etoposide—muscle cancer	0.000947	0.00494	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.000939	0.00491	CcSEcCtD
Sitagliptin—Anaphylactic shock—Vincristine—muscle cancer	0.000921	0.00481	CcSEcCtD
Sitagliptin—Infection—Vincristine—muscle cancer	0.000915	0.00478	CcSEcCtD
Sitagliptin—Osteoarthritis—Methotrexate—muscle cancer	0.00091	0.00475	CcSEcCtD
Sitagliptin—Nervous system disorder—Vincristine—muscle cancer	0.000904	0.00472	CcSEcCtD
Sitagliptin—Decreased appetite—Dactinomycin—muscle cancer	0.000896	0.00468	CcSEcCtD
Sitagliptin—Fatigue—Dactinomycin—muscle cancer	0.000889	0.00464	CcSEcCtD
Sitagliptin—Back pain—Etoposide—muscle cancer	0.000885	0.00462	CcSEcCtD
Sitagliptin—Pain—Dactinomycin—muscle cancer	0.000882	0.0046	CcSEcCtD
Sitagliptin—Muscle spasms—Etoposide—muscle cancer	0.000879	0.00459	CcSEcCtD
Sitagliptin—Eczema—Doxorubicin—muscle cancer	0.000876	0.00458	CcSEcCtD
Sitagliptin—Renal failure acute—Doxorubicin—muscle cancer	0.000853	0.00445	CcSEcCtD
Sitagliptin—Feeling abnormal—Dactinomycin—muscle cancer	0.00085	0.00444	CcSEcCtD
Sitagliptin—Ill-defined disorder—Etoposide—muscle cancer	0.000848	0.00443	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000843	0.0044	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Vincristine—muscle cancer	0.000839	0.00438	CcSEcCtD
Sitagliptin—Insomnia—Vincristine—muscle cancer	0.000833	0.00435	CcSEcCtD
Sitagliptin—Renal impairment—Doxorubicin—muscle cancer	0.000828	0.00432	CcSEcCtD
Sitagliptin—Malaise—Etoposide—muscle cancer	0.000825	0.00431	CcSEcCtD
Sitagliptin—Breast disorder—Methotrexate—muscle cancer	0.000822	0.00429	CcSEcCtD
Sitagliptin—Vertigo—Etoposide—muscle cancer	0.000822	0.00429	CcSEcCtD
Sitagliptin—Abdominal pain—Dactinomycin—muscle cancer	0.000815	0.00426	CcSEcCtD
Sitagliptin—Hypoglycaemia—Doxorubicin—muscle cancer	0.000807	0.00421	CcSEcCtD
Sitagliptin—Decreased appetite—Vincristine—muscle cancer	0.000801	0.00418	CcSEcCtD
Sitagliptin—Cough—Etoposide—muscle cancer	0.000798	0.00417	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Vincristine—muscle cancer	0.000795	0.00415	CcSEcCtD
Sitagliptin—Fatigue—Vincristine—muscle cancer	0.000794	0.00415	CcSEcCtD
Sitagliptin—Hypertension—Etoposide—muscle cancer	0.00079	0.00412	CcSEcCtD
Sitagliptin—Pain—Vincristine—muscle cancer	0.000788	0.00411	CcSEcCtD
Sitagliptin—Constipation—Vincristine—muscle cancer	0.000788	0.00411	CcSEcCtD
Sitagliptin—Osteoarthritis—Doxorubicin—muscle cancer	0.000788	0.00411	CcSEcCtD
Sitagliptin—Pain in extremity—Doxorubicin—muscle cancer	0.000788	0.00411	CcSEcCtD
Sitagliptin—Migraine—Doxorubicin—muscle cancer	0.000775	0.00405	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.000773	0.00404	CcSEcCtD
Sitagliptin—Pancreatitis—Methotrexate—muscle cancer	0.000771	0.00402	CcSEcCtD
Sitagliptin—Discomfort—Etoposide—muscle cancer	0.000769	0.00402	CcSEcCtD
Sitagliptin—Face oedema—Doxorubicin—muscle cancer	0.00076	0.00397	CcSEcCtD
Sitagliptin—Hypersensitivity—Dactinomycin—muscle cancer	0.00076	0.00397	CcSEcCtD
Sitagliptin—Abdominal discomfort—Methotrexate—muscle cancer	0.000754	0.00394	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Vincristine—muscle cancer	0.000753	0.00393	CcSEcCtD
Sitagliptin—Anaphylactic shock—Etoposide—muscle cancer	0.000746	0.0039	CcSEcCtD
Sitagliptin—Infection—Etoposide—muscle cancer	0.000741	0.00387	CcSEcCtD
Sitagliptin—Asthenia—Dactinomycin—muscle cancer	0.00074	0.00386	CcSEcCtD
Sitagliptin—Blood creatinine increased—Doxorubicin—muscle cancer	0.000738	0.00385	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000731	0.00382	CcSEcCtD
Sitagliptin—Abdominal pain—Vincristine—muscle cancer	0.000728	0.0038	CcSEcCtD
Sitagliptin—Skin disorder—Etoposide—muscle cancer	0.000725	0.00379	CcSEcCtD
Sitagliptin—Erectile dysfunction—Methotrexate—muscle cancer	0.000724	0.00378	CcSEcCtD
Sitagliptin—Abdominal pain upper—Doxorubicin—muscle cancer	0.000719	0.00376	CcSEcCtD
Sitagliptin—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000719	0.00376	CcSEcCtD
Sitagliptin—Breast disorder—Doxorubicin—muscle cancer	0.000712	0.00372	CcSEcCtD
Sitagliptin—Diarrhoea—Dactinomycin—muscle cancer	0.000706	0.00368	CcSEcCtD
Sitagliptin—Pneumonia—Methotrexate—muscle cancer	0.000705	0.00368	CcSEcCtD
Sitagliptin—Nasopharyngitis—Doxorubicin—muscle cancer	0.000704	0.00368	CcSEcCtD
Sitagliptin—Infestation NOS—Methotrexate—muscle cancer	0.000701	0.00366	CcSEcCtD
Sitagliptin—Infestation—Methotrexate—muscle cancer	0.000701	0.00366	CcSEcCtD
Sitagliptin—Depression—Methotrexate—muscle cancer	0.000699	0.00365	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000695	0.00363	CcSEcCtD
Sitagliptin—Renal failure—Methotrexate—muscle cancer	0.000689	0.0036	CcSEcCtD
Sitagliptin—Influenza—Doxorubicin—muscle cancer	0.000681	0.00355	CcSEcCtD
Sitagliptin—Hypersensitivity—Vincristine—muscle cancer	0.000679	0.00354	CcSEcCtD
Sitagliptin—Pancreatitis—Doxorubicin—muscle cancer	0.000667	0.00349	CcSEcCtD
Sitagliptin—Somnolence—Etoposide—muscle cancer	0.000663	0.00346	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Methotrexate—muscle cancer	0.000663	0.00346	CcSEcCtD
Sitagliptin—Asthenia—Vincristine—muscle cancer	0.000661	0.00345	CcSEcCtD
Sitagliptin—Vomiting—Dactinomycin—muscle cancer	0.000656	0.00342	CcSEcCtD
Sitagliptin—Bronchitis—Doxorubicin—muscle cancer	0.000655	0.00342	CcSEcCtD
Sitagliptin—Rash—Dactinomycin—muscle cancer	0.00065	0.0034	CcSEcCtD
Sitagliptin—Decreased appetite—Etoposide—muscle cancer	0.000649	0.00339	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Etoposide—muscle cancer	0.000644	0.00336	CcSEcCtD
Sitagliptin—Fatigue—Etoposide—muscle cancer	0.000643	0.00336	CcSEcCtD
Sitagliptin—Pain—Etoposide—muscle cancer	0.000638	0.00333	CcSEcCtD
Sitagliptin—Constipation—Etoposide—muscle cancer	0.000638	0.00333	CcSEcCtD
Sitagliptin—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000633	0.0033	CcSEcCtD
Sitagliptin—Diarrhoea—Vincristine—muscle cancer	0.00063	0.00329	CcSEcCtD
Sitagliptin—Pharyngitis—Methotrexate—muscle cancer	0.000624	0.00326	CcSEcCtD
Sitagliptin—Urinary tract disorder—Methotrexate—muscle cancer	0.000621	0.00324	CcSEcCtD
Sitagliptin—Weight increased—Doxorubicin—muscle cancer	0.000619	0.00323	CcSEcCtD
Sitagliptin—Urethral disorder—Methotrexate—muscle cancer	0.000617	0.00322	CcSEcCtD
Sitagliptin—Feeling abnormal—Etoposide—muscle cancer	0.000615	0.00321	CcSEcCtD
Sitagliptin—Hyperglycaemia—Doxorubicin—muscle cancer	0.000614	0.00321	CcSEcCtD
Sitagliptin—Nausea—Dactinomycin—muscle cancer	0.000613	0.0032	CcSEcCtD
Sitagliptin—Pneumonia—Doxorubicin—muscle cancer	0.00061	0.00319	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Etoposide—muscle cancer	0.00061	0.00319	CcSEcCtD
Sitagliptin—Dizziness—Vincristine—muscle cancer	0.000609	0.00318	CcSEcCtD
Sitagliptin—Infestation NOS—Doxorubicin—muscle cancer	0.000607	0.00317	CcSEcCtD
Sitagliptin—Infestation—Doxorubicin—muscle cancer	0.000607	0.00317	CcSEcCtD
Sitagliptin—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.000602	0.00314	CcSEcCtD
Sitagliptin—Renal failure—Doxorubicin—muscle cancer	0.000597	0.00312	CcSEcCtD
Sitagliptin—Erythema multiforme—Methotrexate—muscle cancer	0.000595	0.00311	CcSEcCtD
Sitagliptin—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000595	0.00311	CcSEcCtD
Sitagliptin—Urticaria—Etoposide—muscle cancer	0.000593	0.0031	CcSEcCtD
Sitagliptin—Abdominal pain—Etoposide—muscle cancer	0.00059	0.00308	CcSEcCtD
Sitagliptin—Urinary tract infection—Doxorubicin—muscle cancer	0.00059	0.00308	CcSEcCtD
Sitagliptin—Eye disorder—Methotrexate—muscle cancer	0.000588	0.00307	CcSEcCtD
Sitagliptin—Vomiting—Vincristine—muscle cancer	0.000586	0.00306	CcSEcCtD
Sitagliptin—Cardiac disorder—Methotrexate—muscle cancer	0.000584	0.00305	CcSEcCtD
Sitagliptin—Rash—Vincristine—muscle cancer	0.000581	0.00303	CcSEcCtD
Sitagliptin—Dermatitis—Vincristine—muscle cancer	0.00058	0.00303	CcSEcCtD
Sitagliptin—Headache—Vincristine—muscle cancer	0.000577	0.00301	CcSEcCtD
Sitagliptin—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000574	0.003	CcSEcCtD
Sitagliptin—Angiopathy—Methotrexate—muscle cancer	0.000571	0.00298	CcSEcCtD
Sitagliptin—Sinusitis—Doxorubicin—muscle cancer	0.000569	0.00297	CcSEcCtD
Sitagliptin—Immune system disorder—Methotrexate—muscle cancer	0.000568	0.00297	CcSEcCtD
Sitagliptin—Mediastinal disorder—Methotrexate—muscle cancer	0.000567	0.00296	CcSEcCtD
Sitagliptin—Mental disorder—Methotrexate—muscle cancer	0.000551	0.00288	CcSEcCtD
Sitagliptin—Hypersensitivity—Etoposide—muscle cancer	0.00055	0.00287	CcSEcCtD
Sitagliptin—Malnutrition—Methotrexate—muscle cancer	0.000548	0.00286	CcSEcCtD
Sitagliptin—Nausea—Vincristine—muscle cancer	0.000547	0.00286	CcSEcCtD
Sitagliptin—Hypoaesthesia—Doxorubicin—muscle cancer	0.000542	0.00283	CcSEcCtD
Sitagliptin—Pharyngitis—Doxorubicin—muscle cancer	0.000541	0.00282	CcSEcCtD
Sitagliptin—Urinary tract disorder—Doxorubicin—muscle cancer	0.000538	0.00281	CcSEcCtD
Sitagliptin—Oedema peripheral—Doxorubicin—muscle cancer	0.000537	0.0028	CcSEcCtD
Sitagliptin—Asthenia—Etoposide—muscle cancer	0.000535	0.0028	CcSEcCtD
Sitagliptin—Connective tissue disorder—Doxorubicin—muscle cancer	0.000535	0.0028	CcSEcCtD
Sitagliptin—Urethral disorder—Doxorubicin—muscle cancer	0.000534	0.00279	CcSEcCtD
Sitagliptin—Back pain—Methotrexate—muscle cancer	0.00053	0.00277	CcSEcCtD
Sitagliptin—Vision blurred—Methotrexate—muscle cancer	0.000516	0.0027	CcSEcCtD
Sitagliptin—Erythema multiforme—Doxorubicin—muscle cancer	0.000515	0.00269	CcSEcCtD
Sitagliptin—Diarrhoea—Etoposide—muscle cancer	0.000511	0.00267	CcSEcCtD
Sitagliptin—Eye disorder—Doxorubicin—muscle cancer	0.000509	0.00266	CcSEcCtD
Sitagliptin—Ill-defined disorder—Methotrexate—muscle cancer	0.000508	0.00265	CcSEcCtD
Sitagliptin—Cardiac disorder—Doxorubicin—muscle cancer	0.000506	0.00264	CcSEcCtD
Sitagliptin—Angiopathy—Doxorubicin—muscle cancer	0.000494	0.00258	CcSEcCtD
Sitagliptin—Malaise—Methotrexate—muscle cancer	0.000494	0.00258	CcSEcCtD
Sitagliptin—Dizziness—Etoposide—muscle cancer	0.000494	0.00258	CcSEcCtD
Sitagliptin—Immune system disorder—Doxorubicin—muscle cancer	0.000492	0.00257	CcSEcCtD
Sitagliptin—Vertigo—Methotrexate—muscle cancer	0.000492	0.00257	CcSEcCtD
Sitagliptin—Mediastinal disorder—Doxorubicin—muscle cancer	0.000491	0.00256	CcSEcCtD
Sitagliptin—Cough—Methotrexate—muscle cancer	0.000478	0.0025	CcSEcCtD
Sitagliptin—Mental disorder—Doxorubicin—muscle cancer	0.000477	0.00249	CcSEcCtD
Sitagliptin—Vomiting—Etoposide—muscle cancer	0.000475	0.00248	CcSEcCtD
Sitagliptin—Malnutrition—Doxorubicin—muscle cancer	0.000474	0.00248	CcSEcCtD
Sitagliptin—Rash—Etoposide—muscle cancer	0.000471	0.00246	CcSEcCtD
Sitagliptin—Dermatitis—Etoposide—muscle cancer	0.00047	0.00246	CcSEcCtD
Sitagliptin—Headache—Etoposide—muscle cancer	0.000468	0.00244	CcSEcCtD
Sitagliptin—Flatulence—Doxorubicin—muscle cancer	0.000467	0.00244	CcSEcCtD
Sitagliptin—Myalgia—Methotrexate—muscle cancer	0.000466	0.00244	CcSEcCtD
Sitagliptin—Arthralgia—Methotrexate—muscle cancer	0.000466	0.00244	CcSEcCtD
Sitagliptin—Tension—Doxorubicin—muscle cancer	0.000465	0.00243	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000463	0.00242	CcSEcCtD
Sitagliptin—Discomfort—Methotrexate—muscle cancer	0.000461	0.00241	CcSEcCtD
Sitagliptin—Nervousness—Doxorubicin—muscle cancer	0.000461	0.00241	CcSEcCtD
Sitagliptin—Back pain—Doxorubicin—muscle cancer	0.000459	0.0024	CcSEcCtD
Sitagliptin—Muscle spasms—Doxorubicin—muscle cancer	0.000456	0.00238	CcSEcCtD
Sitagliptin—Anaphylactic shock—Methotrexate—muscle cancer	0.000447	0.00233	CcSEcCtD
Sitagliptin—Vision blurred—Doxorubicin—muscle cancer	0.000447	0.00233	CcSEcCtD
Sitagliptin—Infection—Methotrexate—muscle cancer	0.000444	0.00232	CcSEcCtD
Sitagliptin—Nausea—Etoposide—muscle cancer	0.000443	0.00231	CcSEcCtD
Sitagliptin—Ill-defined disorder—Doxorubicin—muscle cancer	0.00044	0.0023	CcSEcCtD
Sitagliptin—Nervous system disorder—Methotrexate—muscle cancer	0.000438	0.00229	CcSEcCtD
Sitagliptin—Skin disorder—Methotrexate—muscle cancer	0.000434	0.00227	CcSEcCtD
Sitagliptin—Malaise—Doxorubicin—muscle cancer	0.000428	0.00223	CcSEcCtD
Sitagliptin—Vertigo—Doxorubicin—muscle cancer	0.000426	0.00223	CcSEcCtD
Sitagliptin—Cough—Doxorubicin—muscle cancer	0.000414	0.00216	CcSEcCtD
Sitagliptin—Hypertension—Doxorubicin—muscle cancer	0.000409	0.00214	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000407	0.00213	CcSEcCtD
Sitagliptin—Insomnia—Methotrexate—muscle cancer	0.000404	0.00211	CcSEcCtD
Sitagliptin—Arthralgia—Doxorubicin—muscle cancer	0.000404	0.00211	CcSEcCtD
Sitagliptin—Myalgia—Doxorubicin—muscle cancer	0.000404	0.00211	CcSEcCtD
Sitagliptin—Anxiety—Doxorubicin—muscle cancer	0.000402	0.0021	CcSEcCtD
Sitagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000401	0.00209	CcSEcCtD
Sitagliptin—Discomfort—Doxorubicin—muscle cancer	0.000399	0.00208	CcSEcCtD
Sitagliptin—Somnolence—Methotrexate—muscle cancer	0.000397	0.00208	CcSEcCtD
Sitagliptin—Dry mouth—Doxorubicin—muscle cancer	0.000395	0.00206	CcSEcCtD
Sitagliptin—Dyspepsia—Methotrexate—muscle cancer	0.000394	0.00205	CcSEcCtD
Sitagliptin—Decreased appetite—Methotrexate—muscle cancer	0.000389	0.00203	CcSEcCtD
Sitagliptin—Anaphylactic shock—Doxorubicin—muscle cancer	0.000387	0.00202	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000386	0.00202	CcSEcCtD
Sitagliptin—Fatigue—Methotrexate—muscle cancer	0.000385	0.00201	CcSEcCtD
Sitagliptin—Infection—Doxorubicin—muscle cancer	0.000385	0.00201	CcSEcCtD
Sitagliptin—Pain—Methotrexate—muscle cancer	0.000382	0.002	CcSEcCtD
Sitagliptin—Nervous system disorder—Doxorubicin—muscle cancer	0.00038	0.00198	CcSEcCtD
Sitagliptin—Skin disorder—Doxorubicin—muscle cancer	0.000376	0.00196	CcSEcCtD
Sitagliptin—Feeling abnormal—Methotrexate—muscle cancer	0.000368	0.00192	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Methotrexate—muscle cancer	0.000366	0.00191	CcSEcCtD
Sitagliptin—Urticaria—Methotrexate—muscle cancer	0.000355	0.00185	CcSEcCtD
Sitagliptin—Abdominal pain—Methotrexate—muscle cancer	0.000353	0.00185	CcSEcCtD
Sitagliptin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000353	0.00184	CcSEcCtD
Sitagliptin—Insomnia—Doxorubicin—muscle cancer	0.00035	0.00183	CcSEcCtD
Sitagliptin—Somnolence—Doxorubicin—muscle cancer	0.000344	0.0018	CcSEcCtD
Sitagliptin—Dyspepsia—Doxorubicin—muscle cancer	0.000341	0.00178	CcSEcCtD
Sitagliptin—Decreased appetite—Doxorubicin—muscle cancer	0.000336	0.00176	CcSEcCtD
Sitagliptin—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000334	0.00175	CcSEcCtD
Sitagliptin—Fatigue—Doxorubicin—muscle cancer	0.000334	0.00174	CcSEcCtD
Sitagliptin—Pain—Doxorubicin—muscle cancer	0.000331	0.00173	CcSEcCtD
Sitagliptin—Constipation—Doxorubicin—muscle cancer	0.000331	0.00173	CcSEcCtD
Sitagliptin—Hypersensitivity—Methotrexate—muscle cancer	0.000329	0.00172	CcSEcCtD
Sitagliptin—Asthenia—Methotrexate—muscle cancer	0.000321	0.00167	CcSEcCtD
Sitagliptin—Feeling abnormal—Doxorubicin—muscle cancer	0.000319	0.00167	CcSEcCtD
Sitagliptin—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000317	0.00165	CcSEcCtD
Sitagliptin—Urticaria—Doxorubicin—muscle cancer	0.000308	0.00161	CcSEcCtD
Sitagliptin—Abdominal pain—Doxorubicin—muscle cancer	0.000306	0.0016	CcSEcCtD
Sitagliptin—Diarrhoea—Methotrexate—muscle cancer	0.000306	0.0016	CcSEcCtD
Sitagliptin—Dizziness—Methotrexate—muscle cancer	0.000296	0.00154	CcSEcCtD
Sitagliptin—Hypersensitivity—Doxorubicin—muscle cancer	0.000285	0.00149	CcSEcCtD
Sitagliptin—Vomiting—Methotrexate—muscle cancer	0.000284	0.00148	CcSEcCtD
Sitagliptin—Rash—Methotrexate—muscle cancer	0.000282	0.00147	CcSEcCtD
Sitagliptin—Dermatitis—Methotrexate—muscle cancer	0.000282	0.00147	CcSEcCtD
Sitagliptin—Headache—Methotrexate—muscle cancer	0.00028	0.00146	CcSEcCtD
Sitagliptin—Asthenia—Doxorubicin—muscle cancer	0.000278	0.00145	CcSEcCtD
Sitagliptin—Nausea—Methotrexate—muscle cancer	0.000266	0.00139	CcSEcCtD
Sitagliptin—Diarrhoea—Doxorubicin—muscle cancer	0.000265	0.00138	CcSEcCtD
Sitagliptin—Dizziness—Doxorubicin—muscle cancer	0.000256	0.00134	CcSEcCtD
Sitagliptin—Vomiting—Doxorubicin—muscle cancer	0.000246	0.00129	CcSEcCtD
Sitagliptin—Rash—Doxorubicin—muscle cancer	0.000244	0.00127	CcSEcCtD
Sitagliptin—Dermatitis—Doxorubicin—muscle cancer	0.000244	0.00127	CcSEcCtD
Sitagliptin—Headache—Doxorubicin—muscle cancer	0.000242	0.00127	CcSEcCtD
Sitagliptin—Nausea—Doxorubicin—muscle cancer	0.00023	0.0012	CcSEcCtD
